Madrigal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-06 10:41:15 ET MDGL

Published on 05/06/2026 at 10:41 am EDT

Madrigal Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 94.39 million compared to USD 73.24 million a year ago.